Severe acute toxicity associated with high-dose methotrexate (MTX) therapy:: use of therapeutic drug monitoring and test-dose to guide carboxypeptidase G2 rescue and MTX continuation

被引：20
|
作者：
Esteve, M. -A.
Devictor-Pierre, B.
Galy, G.
Andre, N.
Coze, C.
Lacarelle, B.
Bernard, J. -L.
Monjanel-Mouterde, S.
机构：
[1] CHU Timone, Lab Pharmacocinet & Toxicocinet, F-13005 Marseille, France
[2] CHU Timone, Serv Pediat Oncol, F-13005 Marseille, France
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2007年 / 63卷 / 01期
关键词：
D O I：
10.1007/s00228-006-0212-1
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：39 / 42
页数：4
相关论文
共 14 条
  • [11] Delayed MTX-clearence with severe toxicity after high-dose methotrexate therapy in a child homozygous for the MTHFR C677t polymorphism
    Müler, J
    Kralovánszky, J
    Németh, K
    Adleff, V
    Pap, É
    Fekete, G
    Kovács, G
    TISSUE ANTIGENS, 2004, 64 (04): : 388 - 388
  • [12] Glucarpidase (carboxypeptidase G2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy
    Schwartz, Stefan
    Borner, Klaus
    Mueller, Krystina
    Martus, Peter
    Fischer, Lars
    Korfel, Agnieszka
    Auton, Timothy
    Thiel, Eckhard
    ONCOLOGIST, 2007, 12 (11): : 1299 - 1308
  • [13] What is the Best Therapy for Toxicity in the Setting of Methotrexate-Associated Acute Kidney Injury: High-Flux Hemodialysis or Carboxypeptidase G2?
    Kumar, Neelja
    Shirali, Anushree C.
    SEMINARS IN DIALYSIS, 2014, 27 (03) : 226 - 228
  • [14] Toxicity and risk factors contributing to delayed methotrexate (MTX) elimination in Adult/Elderly patients (pts) treated with high-dose methotrexate therapy (HDMTX), a 2-year, single center survey.
    Schwartz, Stefan
    Martus, Peter
    Ludwig, Wolf-Dieter
    Arnold, Renate
    Ruhnke, Markus
    Korfel, Agnieszka
    Kopitzke, David
    Auton, Tim
    Thiel, Eckhard
    BLOOD, 2006, 108 (11) : 690A - 690A
12